retatrutide ly3437943 triple agonist glp-1 gip glucagon mechanism Agonism Based Therapies for Obesity | Current Cardiovascular Risk Reports Retatrutide vs Tirzepatide & Semaglutide

Appetite Regulation and Behavior Change Many patients report a reduced desire to eat

Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes

Glucagon-Like Peptide 1 Receptor Activation Augments Cardiac Output and Improves Cardiac Efficiency in Obese Swine After Myocardial Infarction

J.HardyE.et al

For instance, according to the International Diabetes Federation, 537 million individuals were affected by diabetes worldwide in 2021, with more than 75% of adult diabetes cases occurring in low and middle-income countries

According to the World Obesity Atlas, over 4 billion people, or 51% of the global population, by 2035 will suffer from obesity